Potential Hazards of Long-Term Acid Suppression

References

• Soil AH. Mechanisms of action of antisecretory drugs. Scand J Gastroenterol 1986; 21: 1–6, suppl 125
   PubMed Web of Science ®Google Scholar
• Soil AH. Review: Antisecretory drugs: cellular mechanisms of action. Aliment Pharmacol Ther 1987; 1: 77–89
   PubMedGoogle Scholar
• Wolfe M M, Soil AH. The physiology of gastric acid secretion. N Engl J Med 1988; 319(26)1707–1715
   PubMed Web of Science ®Google Scholar
• Black J W, Duncan W AM, Durant G J, Ganellin CR, Parsons ME. Definition and antagonism of histamine H2-receptors. Nature 1972; 236: 385–390
   PubMed Web of Science ®Google Scholar
• Ganellin R. The characterisation and development of cimetidine as a histamine H2-receptor antagonist. Proceedings of a national symposium on cimetidine., C Harvengt, et al. Excerpta Medica, Oxford 1978; 1–13
   Google Scholar
• Brittain R T, Daly M J, Jack D, Martin L E, Stables R, Sutherland M. The outline of the animal pharmacology of ranitidine. The clinical use of ranitidine, JJ Misiewich, KC Wormsley. Medical Publications Foundation, Oxford 1982; 1–10
   Google Scholar
• Brogden R N, Carmine A A, Heel R C, Speight T M, Avery GS. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 1982; 24: 267–303
   PubMed Web of Science ®Google Scholar
• Brittain R T, Jack D. Histamine H2-antagonists: past, present and future. Receptors and the upper gastrointestinal tract, BI Hirschowitz, JG Spenny. Advanced Therapeutic Communications Inc, New York 1983; 174–186
   Google Scholar
• Betton G R, Salmon GK. Pathology of the fore-stomach in rats treated for 1 year with a new histamine H2 receptor antagonist SK&F 93479 trihydrochloride. Scand J Gastroenterol 1984; 19: 103–108, suppl 101
   Google Scholar
• Streett C S, Cimprich R E, Robertson JL. Pathological findings in the stomachs of rats treated with the H-,-receptor antagonist tiotidine. Scand J Gastroenterol 1984; 19: 109–177, suppl 101
   Web of Science ®Google Scholar
• Humphray J M, Bays D E, Brittain R T, Reeves J J, Stables R. Sufotidine: a competitive and long acting Hi receptor antagonist. Br J Pharmacol 1988; 95: 749
   Google Scholar
• Fellenius E, Berglindh T, Sachs`, et al. Substituted benzimidazoles inhibit secretion blocking (H+ + K+) ATPase. Nature 1981; 290: 159–161
   PubMed Web of Science ®Google Scholar
• Brittain R T, Jack D, Reeves J J, Stables R. Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an unsurmountable histamine Hi receptor blocking drug. Br J Pharmacol 1985; 85: 843–847
   PubMed Web of Science ®Google Scholar
• Poynter D, Pick C R, Harcourt R A, et al. Association of long lasting unsurmountable histamine Hi blockade and gastric carcinoid tumours in the rat. Gut 1985; 26: 1284–1295
   PubMed Web of Science ®Google Scholar
• Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20: 53–69, suppl 108
   Web of Science ®Google Scholar
• Poynter D, Selway S AM, Papworth S A, Riches SR. Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine Hi blockade. Gut 1986; 27: 1338–1346
   PubMed Web of Science ®Google Scholar
• Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986; 35: 42–55, suppl 1
   PubMed Web of Science ®Google Scholar
• Betton G R, Salmon GK. Neuroendocrine (carcinoid) tumours of the glandular stomach of the rat following treatment with an Hi-receptor antagonist. Arch Toxicol 1986; 471, suppl 9
   Google Scholar
• Harleman J H, Betton G R, Dormer G, McCrossan M. Gastric neuroendocrine cell hyperplasia after treatment with the long acting potent H2-receptor antagonist SK&F 93479. Scand J Gastroenterol 1987; 22: 595–600
   PubMed Web of Science ®Google Scholar
• Streett C S, Robertson J L, Crissman JW. Morphologic stomach findings in rats and mice treated with the H2 receptor antagonists ICI125 211 andICI162 846. Toxicol Path 1988; 16: 299–304
   PubMed Web of Science ®Google Scholar
• Hirth R S, Evans L D, Buroker R A, Oleson FB. Gastric entero-chromaffin-like cell hyperplasia and neoplasia in the rat: an indirect effect of the histamine Hi receptor antagonist BL-6341. Toxicol Path 1988; 16: 273–287
   PubMed Web of Science ®Google Scholar
• Sundler F, Hakanson R, Carlsson E, Larsson H, Mattson H. Hypergastrinaemia after blockade of acid secretion in the rat: trophic effects. Digestion 1986; 35: 56–69, suppl 1
   PubMed Web of Science ®Google Scholar
• Creutztfeldt W, Stockmann F, Conlon J M, Folsch U R, Bonatz G, Wulfrath M. Effect of short and long term feeding of omeprazole on rat gastric endocrine cells. Digestion 1986; 35: 84–97, suppl 1
   PubMedGoogle Scholar
• Blom H. Alterations in gastric mucosal morphology induced by long-term treatment with omeprazole in rats. Digestion 1986; 35: 98–105, suppl 1
   PubMedGoogle Scholar
• Harrison C, Jenner W N, Martin L E, Young SN. Radioimmunoassay of loxtidine and ranitidine in biological fluids. Biochem Soc Trans 1983; 11: 713–714
   Google Scholar
• Larsson H, Hakanson R, Mattson H, Ryberg B, Sundler F, Carlsson E. Omeprazole: its influence on gastric acid secretion, gastrin and ECL cells. Toxicol Path 1988; 16: 267–272
   PubMed Web of Science ®Google Scholar
• Penston J, Wormsley KG. Achlorhydria: hypergastrinaemia: carcinoids. A flawed hypothesis?. Gut 1987; 28: 488–505
   PubMed Web of Science ®Google Scholar
• Wormsley KG. Is chronic long term inhibition of gastric secretion really dangerous?. Scand J Gastroenterol 1988; 23: 166–174, suppl 146
   Web of Science ®Google Scholar
• Drasar B S, Shiner M, McLeod GM. Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract of healthy and achlorhydric persons. Gastroenterology 1969; 56: 71–79
   PubMed Web of Science ®Google Scholar
• Giannella R A, Broitmann S A, Zamcheck N. Gastric acid barrier to ingested microorganisms in man. Studies in vivo and in vitro. Gut 1972; 13: 251–256
   PubMed Web of Science ®Google Scholar
• Cook GC. Infective gastroenteritis and its relationship to gastric acidity. Scand J Gastroenterol 1985; 20: 17–22, suppl 111
   Web of Science ®Google Scholar
• Stockbruegger RW. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol 1985; 20: 7–16, suppl 111
   Web of Science ®Google Scholar
• Howden C W, Hunt RH. Relationship between gastric secretion and infection. Gut 1987; 28: 96–107
   PubMed Web of Science ®Google Scholar
• Hill MJ. Aetiology and micro-environment of gastric cancer. Gastric carcinoma, MI Filipe, JR Jass. Churchill Livingstone, Edinburgh 1986; 11–19
   Google Scholar
• Leach S A, Hill MJ. The effects of the sustained and profound inhibition of gastric acid production on gut flora. Res Clin Forums 1990; 12: 139–151
   Google Scholar
• Calmels S, Bereziat J C, Oshima H, Bartsch H. Bacterial formation of N-nitroso compounds (NOC) in the rat stomach after omeprazole induced achlorhydria. N-nitroso compounds, mycotoxins and tobacco smoke: relevance to human cancer, IK O'Neill, J Chen, H Barsch. I ARC Scientific Publications, Lyon, Publication No. 105., in press
   Google Scholar
• Rowlatt UF. Neoplasms of the alimentary canal of rats and mice. Pathology of rats and mice, E Cotchin, FJC Roe. Blackwell Scientific Publications, Oxford 1967; 57–84
   Google Scholar
• Nagayo. Tumours of the stomach. Turusoved. Pathology of tumours of laboratory animals. IARC, Lyon 1973; Vol. I.: 101–106, Rat, Part I.
   Google Scholar
• Sher SP. Tumours in control hamsters, rats and mice: literature tabulation. CRC Crit Rev Toxicol 1982; 10: 49–79
   Web of Science ®Google Scholar
• Stewart H L, Hare W V, Lorenz E, Bennett JB. Adenocarcinoma and other lesions of the glandular stomach of mice following intramural injection of 20-methyl-cholanthrene. J Natl Cane Inst 1949; 10: 359–360
   PubMedGoogle Scholar
• Stewart HL. Experimental cancer of the alimentary tract. The pathophysiology of cancer, F Homburger, WH Fishman. Cassell, London 1953; 3–45
   Google Scholar
• Stewart H L, Hare W V, Bennett JG. Tumoursof the glandular stomach induced in mice of six strains by intramural injection of 20-methylcholanthrene. J Natl Cane Inst 1953; 14: 105–125
   PubMedGoogle Scholar
• Stewart H L, Snell K C, Hare WV. Histopatho-genesis of carcinoma induced in the glandular stomach of C57BL mice by the intramural injection of 20-methylcholanthrene. J Natl Cane Inst 1958; 21: 999–1019
   PubMedGoogle Scholar
• Stewart H L, Snell K C, Morris HP. The combined effects of 3-methylcholanthrene and N.N,2,7, fluorenylenebisacetamide on the induction of cancer of the glandular stomach of the rat. J Natl Cane Inst 1965; 64: 157–174
   Google Scholar
• Sugimura T, Nagao M, Okada Y. Carcinogenic action of N-methyl-N-nitro-N-nitrosoguanidine. Nature 1966; 210: 962–963
   PubMedGoogle Scholar
• Sugimura T, Fujimura S. Tumour production in glandular stomach of rat by N-methyl-N-nitro-N-nitrosoguanidine. Nature 1967; 216: 943
   PubMed Web of Science ®Google Scholar
• Black W C, Haffner HE. Diffuse hyperplasia of gastric argvrophil cells and multiple carcinoid tumours. Cancer 1968; 21: 1080–1099
   PubMed Web of Science ®Google Scholar
• Rubin W. Proliferation of endocrine-like (entero-chromaffin) cells in atrophic gastric mucosa. Gastroenterology 1969; 57: 641–648
   PubMed Web of Science ®Google Scholar
• Capclla C, Polak J M, Timson C M, Frigcrio B, Solcia E. Gastric carcinoids of argyrophilic ECL cells. Ultrastruct Path 1980; 1: 411–418
   PubMedGoogle Scholar
• Bordi C. Nonantral gastric carcinoids and hyper-gastrinaemia. Arch Surg 1981; 116: 1238
   PubMedGoogle Scholar
• Carney J A, Go V LW, Fairbanks V F, Moore S B, Alport E C, Nora FE. The syndrome of gastric argyrophil carcinoid tumours and nonantral gastric atrophy. Ann Intern Med 1983; 99: 761–766
   PubMed Web of Science ®Google Scholar
• Bordi C, Bertele A, Davighi M C, Pilato F, Carfagna G, Missale G. Clinical and pathological associations of argyrophil cell hyperplasias of the gastric mucosa. Appl Path 1984; 2: 282–291
   PubMedGoogle Scholar
• Harvey R F, Bradshaw M J, Davidson CM, Wilkinson SP, Davies PS. Multifocal gastric carcinoid tumours, achlorhydria and hypergastrinaemia. Lancet 1985; 1: 951–953
   PubMed Web of Science ®Google Scholar
• Borch K, Renvall H, Licdberg G, Andersen BN. Relations between circulating gastrin and endocrine proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 1986; 21: 357–363
   PubMed Web of Science ®Google Scholar
• Bordi C, Pilato F, Carfagna G, et al. Argyrophil cell hyperplasia of fundic muscoa in patients with chronic atrophic gastritis. Digestion 1986; 35: 130–143, suppl 1
   PubMedGoogle Scholar
• Borch K, Renvall H, Liedberg G. Endocrine cell proliferation and carcinoid development: a review of new aspects of hypergastrinaemic atrophic gastritis. Digestion 1986; 35: 106–115, suppl 1
   PubMed Web of Science ®Google Scholar
• Cattan D, Roucayrol A M, Launay J M, et al. Circulating gastrin, endocrine cells, histamine content and histidine decarboxylase activity in atrophic gastritis. Gastroenterology 1989; 97: 586–596
   PubMed Web of Science ®Google Scholar
• Larsson LI, Rehfeld J, Stockbriigger R, et al. Mixed endocrine gastric tumours associated with hypergastrinaemia of antral origin. Am J Pathol 1978; 93: 53–68
   PubMed Web of Science ®Google Scholar
• Al Hanis, Greenberg H. Pernicious anaemia and the development of carcinoid tumours of the stomach. JAMA 1978; 239: 1160–1161
   PubMedGoogle Scholar
• Wilander E. Achylia, pernicious anaemia, ECL cells and gastric carcinoids [Letter). Virchows Arch [Pathol Anat] 1980; 387: 371–373
   PubMedGoogle Scholar
• Borch K, Renvall H, Liedberg. Gastric endocrine cell hyperplasia and carcinoid tumours in pernicious anaemia. Gastroenterology 1985; 88: 638–648
   PubMed Web of Science ®Google Scholar
• Rode J, Dhillon A P, Papadaki L, et al. Pernicious anaemia and mucosal endocrine cell proliferation of the non-antral stomach. Gut 1986; 27: 789–798
   PubMed Web of Science ®Google Scholar
• Bordi C, Cocconi G, Togni R, Vezzadini P, Missale P. Gastric endocrine cell proliferation association with Zollinger Ellison syndrome. Arch Pathol 1974; 98: 274–278
   PubMedGoogle Scholar
• Walker IR, Strickland RG, Ungar B, McKay R. Simple atrophic gastritis and gastric carcinoma. Gut 1971; 12: 906–913
   PubMed Web of Science ®Google Scholar
• Siurala M, Lehtola J, Ihamaki T. Atrophic gastritis and its sequelae. Results of 19–23 years follow up examinations. Scand J Gastroenterol 1974; 9: 441–446
   PubMed Web of Science ®Google Scholar
• Morson BC, Dawson IMP. Gastrointestinal pathology.2nd ed. Blackwell Scientific Publications, Oxford 1979
   Google Scholar
• Suirala M, Varis K, Sipponen P. Carcinogenesis in the foregut. II. Gastric carcinoma. Foregut, JH Baron, FG Moody. Butterworths, London 1981; 276–312
   Google Scholar
• Cheli R., Giacosa A. Atrophic gastritis. Precancerous lesions of the gastrointestinal tract, P Sherlock, BC. Morson, U Versonesi. Raven Press, New York 1983; 155–169
   Google Scholar
• Sipponen P, Kekki M, Siurala M. Precancerous conditions. Gastric cancer, current problems in tumour pathology, MI Filipe, JR Jass. Churchill Livingstone, London 1985; 152–171
   Google Scholar
• Svendsen J H, Dahl C, Svendsen L B, Christiansen PM. Gastric cancer risk in achlorhydric patients. A long term follow up study. Scand J Gastroenterol 1986; 21: 16–20
   PubMed Web of Science ®Google Scholar
• Sipponen P. Atrophic gastritis. Risk of gastric cancer. Res Clin Forums 1990; 12: 95–106
   Google Scholar
• Morson BC. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955; 9: 377–385
   PubMed Web of Science ®Google Scholar
• Filipe M I, Jass JR. Intestinal metaplasia subtypes and cancer risk. Gastric carcinoma, MI Filipe, JR Jass. Churchill Livingstone, Edinburgh 1986; 87–115
   Google Scholar
• Bosnian FT. Neuroendocrine cells in non-neuro-endocrine tumours. Evolution and tumour pathology of the neuroendocrine system, S Falkmer, S Hakanson, F Sundler. Elsevier, Amsterdam 1984; 519–543
   Google Scholar
• Bonar S F, Sweeney EC. The prevalence, prognostic significance and hormonal content of endocrine cells in gastric cancer. Histopathology 1986; 10: 53–63
   PubMedGoogle Scholar
• Siurala M, Isokoski M, Varis K, Kekki M. Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol 1968; 3: 211–223
   PubMed Web of Science ®Google Scholar
• Day DW. Biopsy pathology of the oesophagus, stomach and duodenum. Chapman and Hall, London 1986; 85–116
   Google Scholar
• Giacosa A, Cheli R. Gastrite chronique dans I'ulcere duodenal. Gastroenterol Clin Biol 1979; 5: 215A
   Google Scholar
• Lee FI. High dose ranitidine in the treatment of duodenal ulcer. Am J Gastroenterol 1989; 84: 1337–1338
   PubMedGoogle Scholar
• Graham D Y, Van Deventer G, Humphries T J, Cagloila A J, Berman R S, Walton-Bowen K. The natural history of duodenal ulcer disease is unchanged following treatment with omeprazole, ranitidine or placebo. Am J Gastroenterol 1989; 84: 1184
   Google Scholar
• Pritchard P J, Yeomans N D, Mihaly G W, et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 1985; 88: 64–69
   PubMedGoogle Scholar
• Walt R P, Gomes M, de Wood EFA C, Logan L H, Pounder RE. Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J 1983; 287: 12–14
   PubMed Web of Science ®Google Scholar
• Lanzon-Miller S, Pounder R E, Hamilton M R, et al. Twentyfour hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987; 1: 239–256
   PubMedGoogle Scholar
• Sharma B K, Santana I A, Wood E C, et al. Intragastric bacterial activity and nitrosation before, during and after treatment with omeprazole. Br Med J 1984; 289: 717–719
   PubMed Web of Science ®Google Scholar
• Meyrick Thomas J, Misiewicz J J, Cook A R, et al. Effects of one year's treatment with ranitidine and the truncal vagotomy on gastric contents. Gut 1987; 28: 726–738
   PubMedGoogle Scholar